Use access key #2 to skip to page content.
$21.47 -0.23 (-1.06%)
1/9/2009 4:00 PM

Endo Pharmaceuticals (ENDP)

CAPS Rating:
****

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.

View All Commentary (ENDP)

Recs

0

Avatar quipo16 (22.45) Submitted: 4/30/08 12:57 PM : Outperform Start Price: $25.16 ENDP Score: 21.49

Rapinyl and Ketoprofen are in phase III and should push profits up in the next couple years.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links